Skip to main content
Clinical Trials/ChiCTR1800019667
ChiCTR1800019667Active, not recruitingPhase 4

地佐辛对儿童芬太尼诱导咳嗽的效果观察

课题科研经费1 site in 1 countryStarted: November 26, 2018Last updated:

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor
Locations
1
Primary Endpoint
芬太尼诱导咳嗽的发生率和严重程度

Study Overview

Brief Summary

麻醉诱导时静脉注射单剂量芬太尼咳嗽的发生率高达 28-65%。芬太尼诱导咳嗽会导致严重的呼吸道问题,包括剧烈咳嗽、甚至屏住呼吸,支气管痉挛等,本研究观察提前静脉注射地佐辛,观察对芬太尼诱导咳嗽的预防效果。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
未说明

Eligibility Criteria

Ages
2 to 7 (—)
Sex
All

Inclusion Criteria

  • 选择 2-7 岁,ASAI 级,行眼科手术的患儿

Exclusion Criteria

  • 有自发性咳嗽;不正常的呼吸道;气道高反应性;3 周内商户到感染病史;伴有认知功能落后或者发育落后,还有对我们选择的麻醉药物过敏的。

Arms & Interventions

地佐辛组

对照组

Outcomes

Primary Outcomes

芬太尼诱导咳嗽的发生率和严重程度

Secondary Outcomes

  • 疼痛评分

Investigators

Sponsor
课题科研经费

Study Sites (1)

Loading locations...

Similar Trials